Vikas Gupta

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial”.

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-025-03572-3

N/A

0.664DataRank · unranked

40 citations

Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds +23 more

Comparison of outcomes of HCT in blast phase of BCR-ABL1− MPN with de novo AML and with AML following MDS

Blood Advances(2020)10.1182/bloodadvances.2020002621

N/A

0.449DataRank · unranked

19 citations

Soyoung Kim, Zhen‐Huan Hu, Ying Liu, Mahmoud Aljurf, Ulrike Bacher +37 more

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis

Nature Communications(2022)10.1038/s41467-022-32986-7

N/A

0.396DataRank · unranked

13 citations

Weiyin Zhou, Youjin Wang, Kristine Jones, Wen Luo, Casey Dagnall +26 more

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes

Blood Advances(2023)10.1182/bloodadvances.2023010882

N/A

0.265DataRank · unranked

4 citations

Derek W. Brown, Weiyin Zhou, Kristine Jones, Wen Luo, Andrew St. Martin +13 more

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration

Haematologica(2023)10.3324/haematol.2023.283426

N/A

0DataRank · unranked

13 citations

Hua‐Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall +18 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Blood Advances(2024)10.1182/bloodadvances.2024013451

N/A

0DataRank · unranked

14 citations

Noel Estrada‐Merly, María Queralt Salas, Soyoung Kim, Jakob D. DeVos, Min Chen +59 more

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Haematologica(2023)10.3324/haematol.2022.282411

N/A

0DataRank · unranked

17 citations

Lynda Foltz, Vikas Gupta, Robert P. Hasserjian, Taghi Manshouri, John Mascarenhas +15 more

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Haematologica(2023)10.3324/haematol.2022.281958

N/A

0DataRank · unranked

33 citations

Soyoung Kim, Noel Estrada‐Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal +44 more

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Blood Advances(2023)10.1182/bloodadvances.2023009886

N/A

0DataRank · unranked

20 citations

Donal P. McLornan, Kwang Woo Ahn, Noel Estrada‐Merly, Juan Carlos Hernández‐Boluda, Sergio Giralt +46 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more